Literature DB >> 11766883

Neurocan: a brain chondroitin sulfate proteoglycan.

U Rauch1, K Feng, X H Zhou.   

Abstract

Neurocan is a chondroitin sulfate proteoglycan of the lectican family and a component of the extracellular matrix of the central nervous system. It is mainly expressed during modeling and remodeling stages of this tissue. Neurocan can bind to various structural extracellular matrix components, such as hyaluronan, heparin, tenascin-C and tenascin-R, and the growth and mobility factors FGF-2, HB-GAM, and amphoterin. Neurocan can also interact with several cell surface molecules, such as N-CAM, L1/Ng-CAM, TAG-1/axonin-1, and an N-cadherin-binding N-acetyl-galactosamine-phosphoryl-transferase, and in vitro studies have shown that neurocan is able to modulate the cell-binding and neurite outgrowth promoting activites of these molecules. Current analysis of the molecular structures and substructures involved in homophilic and heterophilic interactions of these molecules and complementary loss-of-function mutations might shed some light on the roles played by neurocan and interacting molecules in the fine tuning of the nervous system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11766883     DOI: 10.1007/PL00000822

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  28 in total

1.  Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury.

Authors:  Ellen M Andrews; Rebekah J Richards; Feng Q Yin; Mariano S Viapiano; Lyn B Jakeman
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

2.  Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3.

Authors:  James M Massey; Jeremy Amps; Mariano S Viapiano; Russell T Matthews; Michelle R Wagoner; Christopher M Whitaker; Warren Alilain; Alicia L Yonkof; Abdelnaby Khalyfa; Nigel G F Cooper; Jerry Silver; Stephen M Onifer
Journal:  Exp Neurol       Date:  2007-04-12       Impact factor: 5.330

Review 3.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

Review 4.  Auxiliary and autonomous proteoglycan signaling networks.

Authors:  Arye Elfenbein; Michael Simons
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

5.  A coarse-grained molecular model for glycosaminoglycans: application to chondroitin, chondroitin sulfate, and hyaluronic acid.

Authors:  Mark Bathe; Gregory C Rutledge; Alan J Grodzinsky; Bruce Tidor
Journal:  Biophys J       Date:  2005-04-01       Impact factor: 4.033

6.  Effects of SNPs at newly identified lipids loci on blood lipid levels and risk of coronary heart disease in Chinese Han population: a case control study.

Authors:  Ke Zhuang; Wencai Zhang; Xiaobo Zhang; Fangqin Wu; Longxian Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-08-07

7.  Arylsulfatase B modulates neurite outgrowth via astrocyte chondroitin-4-sulfate: dysregulation by ethanol.

Authors:  Xiaolu Zhang; Sumit Bhattacharyya; Handojo Kusumo; Charles R Goodlett; Joanne K Tobacman; Marina Guizzetti
Journal:  Glia       Date:  2013-12-06       Impact factor: 7.452

8.  Chondroitin sulfate effects on neural stem cell differentiation.

Authors:  David R Canning; Natalie R Brelsford; Neil W Lovett
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-08-19       Impact factor: 2.416

9.  Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity.

Authors:  Alexis Gorden; Rongze Yang; Laura M Yerges-Armstrong; Kathleen A Ryan; Elizabeth Speliotes; Ingrid B Borecki; Tamara B Harris; Xin Chu; G Craig Wood; Christopher D Still; Alan R Shuldiner; Glenn S Gerhard
Journal:  Hum Hered       Date:  2013-04-10       Impact factor: 0.444

10.  Deep Sequencing of Complex Proteoglycans: A Novel Strategy for High Coverage and Site-specific Identification of Glycosaminoglycan-linked Peptides.

Authors:  Joshua A Klein; Le Meng; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2018-05-17       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.